SCHEMBL16235741

SCHEMBL16235741

COc1nc(Cl)ccc1N(c1cc(Cl)cc(Cl)c1)S(C)(=O)=O

nearest known ligand 0.33

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ CCR4 P51679 3/20 0.33
▸ ALDH1A1 P00352 2/20 0.33
▸ GAA P10253 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ NPC1 O15118 1/20 0.32
▸ RAB9A P51151 1/20 0.32
▸ EDNRA P25101 1/20 0.32
▸ HTT P42858 1/20 0.32
▸ MERTK Q12866 1/20 0.32
▸ TDP2 O95551 1/20 0.31
▸ NSD2 O96028 1/20 0.31
▸ KDM4E B2RXH2 1/20 0.30
▸ LRRK2 Q5S007 1/20 0.30
▸ SCN9A Q15858 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16235515 0.68 ALDH1A1 (0.30) ALDH1A1
SCHEMBL16235405 0.66 GPBAR1 (0.37) ALDH1A1
SCHEMBL16235321 0.66 ACLY (0.33) ALDH1A1
SCHEMBL16235142 0.66 GPBAR1 (0.34) ALDH1A1
SCHEMBL19682808 0.63 TRPV4 (0.47) CCR4ALDH1A1GAAHPGDSMN1; SMN2
SCHEMBL16235389 0.63 HTT (0.30) CCR4HTTSCN9A
SCHEMBL16235739 0.63 S100A9 (0.46) CCR4ALDH1A1HPGDKDM4E
SCHEMBL16235458 0.63 ATF1 (0.35) CCR4HPGDEDNRAHTTKDM4E
SCHEMBL2116753 0.62 ALDH1A1 (0.41) CCR4ALDH1A1GAAHPGDSMN1; SMN2
SCHEMBL20919257 0.61 PDCD1LG2 (0.40) ALDH1A1GAAHPGDSMN1; SMN2EDNRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2925743-A1 N-(HETEROARYL)-SULFONAMIDE DERIVATIVES USEFUL AS S100-INHIBITORS Active Biotech AB (SE) 2015-10-07 — — EP disclosed
WO-2014184234-A1 N-(HETEROARYL)-SULFONAMIDE DERIVATIVES USEFUL AS S100-INHIBITORS ACTIVE BIOTECH AB (SE) 2014-11-20 — — WO disclosed
Send feedback